Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871
Study Information
Alliance Study ID: CALGB-60805
NCT Study ID (ClinicalTrials.gov): NCT01015963
Alliance Committee: Experimental Therapeutics
Disease or Cancer Type: Breast Cancer, Genitourinary Cancers – Kidney / Bladder / Urothelial / Testicular, Head & Neck Cancers, Lung Cancer & Mesothelioma, Other Cancer
Alliance Study Chair: Lionel D. Lewis, MD
Status: COMPLETED
Study Description
This research trial studies deoxyribonucleic acid (DNA) in blood samples from Caucasian and African-American cancer patients who received docetaxel on clinical trial CLB-9871. Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors learn more about how docetaxel is used by the body.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information